Transplantation, HomologousHematopoietic Stem Cell TransplantationTransplantation, AutologousBone Marrow TransplantationGraft vs Host DiseaseTransplantation ConditioningPeripheral Blood Stem Cell TransplantationBlood Transfusion, AutologousHematologic NeoplasmsLymphocyte Culture Test, MixedGraft SurvivalTransplantation ChimeraIsoantigensT-LymphocytesTransplantation, IsogeneicStem Cell TransplantationGraft vs Tumor EffectTreatment OutcomeWhole-Body IrradiationCombined Modality TherapyLeukemiaRecurrenceHistocompatibilityTissue DonorsRemission InductionLymphocyte ActivationCytotoxicity, ImmunologicGraft vs Leukemia EffectCyclophosphamideSkin TransplantationBusulfanMelphalanHistocompatibility TestingHematopoietic Stem Cell MobilizationLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphoma, Non-HodgkinImmunosuppressionGraft vs Host ReactionGranulocyte Colony-Stimulating FactorDendritic CellsMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsTransplantation ImmunologyGraft RejectionRetrospective StudiesSurvival AnalysisTime FactorsT-Lymphocytes, CytotoxicAnemia, AplasticMyeloablative AgonistsMice, Inbred BALB CMice, Inbred C57BLLymphocyte DepletionAntigens, CD34Immunosuppressive AgentsSalvage TherapySpleenLymphocytesHLA AntigensSurvival RatePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukocyte TransfusionImmune ToleranceVidarabineImmunotherapy, AdoptiveRadiation ChimeraLeukapheresisCarmustineAcute DiseaseCells, CulturedEtoposideCytotoxicity Tests, ImmunologicCytarabineBlood Component RemovalHodgkin DiseaseNeoplasm, ResidualHematopoietic Stem CellsMyelodysplastic SyndromesKiller Cells, NaturalCD4-Positive T-LymphocytesBlood TransfusionHistocompatibility AntigensSiblingsFlow CytometryInterleukin-2CD8-Positive T-LymphocytesCytomegalovirus InfectionsChimerismAntigens, CDImmunophenotypingImmunotherapyMice, Inbred StrainsTransplantation ToleranceBone Marrow CellsFollow-Up StudiesAntibodies, MonoclonalT-Lymphocytes, RegulatoryHematopoiesisMice, Inbred C3H